Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Cash from Investing Activities: 2020-2023

Historic Cash from Investing Activities for Candel Therapeutics (CADL) over the last 3 years, with Dec 2023 value amounting to -$27,000.

  • Candel Therapeutics' Cash from Investing Activities rose 90.22% to -$27,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$280,000, marking a year-over-year increase of 78.41%. This contributed to the annual value of -$16,000 for FY2024, which is 94.29% up from last year.
  • As of Q4 2023, Candel Therapeutics' Cash from Investing Activities stood at -$27,000, which was up 73.79% from -$103,000 recorded in Q3 2023.
  • In the past 5 years, Candel Therapeutics' Cash from Investing Activities ranged from a high of $20.2 million in Q4 2020 and a low of -$732,000 during Q3 2020.
  • Over the past 3 years, Candel Therapeutics' median Cash from Investing Activities value was -$222,000 (recorded in 2021), while the average stood at -$284,333.
  • Per our database at Business Quant, Candel Therapeutics' Cash from Investing Activities crashed by 102.50% in 2021 and then soared by 111.11% in 2023.
  • Over the past 4 years, Candel Therapeutics' Cash from Investing Activities (Quarterly) stood at $20.2 million in 2020, then plummeted by 102.50% to -$504,000 in 2021, then soared by 45.24% to -$276,000 in 2022, then soared by 90.22% to -$27,000 in 2023.
  • Its Cash from Investing Activities was -$27,000 in Q4 2023, compared to -$103,000 in Q3 2023 and -$169,000 in Q2 2023.